会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • PHARMACEUTICAL COMPOSITIONS FOR STIMULATING RECONSTRUCTION OF HEMOPOIETIC MICROENVIRONMENT
    • 用于刺激重建微生态环境的药物组合物
    • WO1995000166A1
    • 1995-01-05
    • PCT/GB1994001309
    • 1994-06-17
    • YISSUM RESEARCH DEVELOPMENT COMPANYGOLDIN, Douglas, MichaelBAB, ItaiMUHLRAD, AndrasCHOREV, MichaelSHTEYER, ArieSLAVIN, ShimonMANSUR, NuraGUREVITCH, Olga
    • YISSUM RESEARCH DEVELOPMENT COMPANYGOLDIN, Douglas, Michael
    • A61K37/36
    • C07K14/51A61K38/00Y10S530/84Y10S530/841
    • The invention relates to a pharmaceutical composition for stimulating reconstruction of hemopoietic microenvironment comprising a therapeutically effective amount of a peptide having an amino acide sequence Ala-Leu-Lys-Arg-Gln-Gly-Arg-Thr-Leu-Try-Gly-Phe-Gly-Gly- (OGP), or conservative amino acid substitution or deletion thereof, or an oligopeptide having molecular weight of from 200 to 2,000 wherein the four C-terminal amino acid residues are identical with those of the said OGP, with the penultimate Gly optionally replaced by His, or a mixture thereof and a pharmaceutically acceptable carrier. A method of stimulating reconstruction of hemopoietic microenvironment in a mammal which comprises administering to said mammal a therapeutically effective amount of a peptide having an amino acid sequence Ala-Leu-Lys-Arg-Gln-Gly-Arg-Thr-Leu-Tyr-Gly-Phe-Gly-Gly (OGP), or conservative amino acid substitution or deletion thereof, or an oligopeptide having molecular weight of from 200 to 2,000 wherein the four C-terminal amino acid residues are identical with those of said OGP, with the penultimates Gly optionally replaced by His, or a mixture thereof.
    • 本发明涉及用于刺激造血微环境重建的药物组合物,其包含治疗有效量的具有氨基酸序列Ala-Leu-Lys-Arg-Gln-Gly-Arg-Thr-Leu-Try-Gly-Phe- Gly-Gly-(OGP)或其保守氨基酸取代或缺失,或分子量为200至2,000的寡肽,其中四个C-末端氨基酸残基与所述OGP的氨基酸残基相同,其中倒数第二 任选地被His替代,或其混合物和药学上可接受的载体。 一种刺激哺乳动物造血微环境重建的方法,其包括向所述哺乳动物施用治疗有效量的具有氨基酸序列Ala-Leu-Lys-Arg-Gln-Gly-Arg-Thr-Leu-Tyr-Gly -Phe-Gly-Gly(OGP)或其保守氨基酸取代或缺失,或分子量为200至2,000的寡肽,其中四个C末端氨基酸残基与所述OGP的氨基酸残基相同, Gly任选被His取代,或其混合物。